Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Taramasso

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Virology Journal|November 24, 2018
Treatment of hepatitis C virus genotype 4 in the DAA eraAntonio Di Biagio, Lucia Taramasso, Giovanni Cenderello
Virulence|March 8, 2016
Bloodstream infections in HIV-infected patientsLucia Taramasso, Paola Tatarelli, Antonio Di Biagio
Current Opinion in Infectious Diseases|December 15, 2025
Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worryLorenzo Costacurta, Antonio Di Biagio, Lucia Taramasso
Expert Opinion on Pharmacotherapy|June 14, 2021
Evaluating fostemsavir as a therapeutic option for patients with HIVMarco Berruti, Rachele Pincino, Lucia Taramasso, et al.
AIDS (London, England)|April 10, 2020
The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimenLucia Taramasso, Marco Berruti, Federica Briano, et al.
Expert Review of Anti-Infective Therapy|June 19, 2012
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapyMatteo Bassetti, Lucia Taramasso, Daniele Roberto Giacobbe, et al.
Journal of the International Association of Providers of AIDS Care|February 26, 2019
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected PatientsNiccolò Riccardi, Filippo Del Puente, Lucia Taramasso, et al.
Expert Review of Anti-Infective Therapy|October 7, 2011
Will new antimicrobials overcome resistance among Gram-negatives?Matteo Bassetti, Francesca Ginocchio, Małgorzata Mikulska, et al.
The New Microbiologica|May 2, 2025
Two-drug regimen with dolutegravir plus lamivudine for HIV treatment in children: a narrative reviewClaudia Bartalucci, Laura Labate, Lucia Taramasso, et al.
Frontiers in Immunology|November 22, 2018
Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIVGilberto Filaci, Daniela Fenoglio, Lucia Taramasso, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Virology Journal|November 24, 2018
Treatment of hepatitis C virus genotype 4 in the DAA eraAntonio Di Biagio, Lucia Taramasso, Giovanni Cenderello
Virulence|March 8, 2016
Bloodstream infections in HIV-infected patientsLucia Taramasso, Paola Tatarelli, Antonio Di Biagio
Current Opinion in Infectious Diseases|December 15, 2025
Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worryLorenzo Costacurta, Antonio Di Biagio, Lucia Taramasso
Expert Opinion on Pharmacotherapy|June 14, 2021
Evaluating fostemsavir as a therapeutic option for patients with HIVMarco Berruti, Rachele Pincino, Lucia Taramasso, et al.
AIDS (London, England)|April 10, 2020
The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimenLucia Taramasso, Marco Berruti, Federica Briano, et al.
Expert Review of Anti-Infective Therapy|June 19, 2012
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapyMatteo Bassetti, Lucia Taramasso, Daniele Roberto Giacobbe, et al.
Journal of the International Association of Providers of AIDS Care|February 26, 2019
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected PatientsNiccolò Riccardi, Filippo Del Puente, Lucia Taramasso, et al.
Expert Review of Anti-Infective Therapy|October 7, 2011
Will new antimicrobials overcome resistance among Gram-negatives?Matteo Bassetti, Francesca Ginocchio, Małgorzata Mikulska, et al.
The New Microbiologica|May 2, 2025
Two-drug regimen with dolutegravir plus lamivudine for HIV treatment in children: a narrative reviewClaudia Bartalucci, Laura Labate, Lucia Taramasso, et al.
Frontiers in Immunology|November 22, 2018
Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIVGilberto Filaci, Daniela Fenoglio, Lucia Taramasso, et al.
Pageof 14